Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease by Antonius T. Otten, Arno R. Bourgonje, Petra P. Horinga, Hedwig H. van der Meulen, Eleonora A. M. Festen, Hendrik M. van Dullemen, Rinse K. Weersma, Coretta C. van Leer-Buter, Gerard Dijkstra, Marijn C. Visschedijk

Get full text